Dr. B J Srinivasa Specialist in Medical Oncology

Area of Expertise

● Dr. Srinivasa B. J. is an adept medical oncology consultant practicing at HCG Cancer Centre, a leading hospital for cancer treatment in Bengaluru.

● He has specialized expertise in administering systemic cancer treatments, namely chemotherapy, immunotherapy, targeted therapy, and hormone therapy.

● Dr. Srinivas is an expert in the management of breast cancer, GI cancer, head and neck cancer, lung cancer, multiple myeloma, and lymphoma.

● He has a specialized interest in clinical research and tumor genetics, through which he aims to make cancer medicine more precise, effective, safe, and patient-focused.

Research & Publications

● Indian subset analysis of a phase IIIb open-label study of afatinib in epidermal growth factor receptor tyrosine kinase inhibitor-naïve patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer. Oncol J India 2021; 5:116-8.

● Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies. Front Oncol. 2021 Jul 9;11:709877.

● Sepsis Mimicking TTP-Case Report and Review of Literature. Journal of Surgery & Anesthesia Research. December 2020:1-2.

● The fundamentals to minimize the culture failure in hematological malignancies. OALib. 2020;07(09):1-6.

● Clinical Profile of Carcinoma Breast Patients Treated with Trastuzumab: A Single Centre Study. Advances in Breast Cancer Research. 2020;09(04):110-118.

● Reversible hypopigmentation with pazopanib. Indian J Med Paediatr Oncol 2018;39:519-20.

● Breast Metastasis from Adenocarcinoma of Lung: A Case Report. SEAJCRR. (2016); 5(5): 2453-2458.

● Combined DPD and UGT1A1 mutation in a single patient: a case report. Journal of Pharmacogenomics & Pharmacoproteomics. 2017;08(01).

● Adenocarcinoma Colon Masquerading as Acute Leukemia. Journal of Case Reports, 2012; 2(2): 67-71.

● Case of fosphenytoin-induced acute cerebellar dysfunction and pituitary bleeding causing central diabetes insipidus in a case of AML M2 during allogenic hematopoietic stem cell transplant. Int J Pharmacol and Clin Sci 2012;1:111-4.

● Primary Rhadbdomyosarcoma of breast. Journal of Case Reports, 2013; 3(1): 130-133.

● Efficacy study of metronomic chemotherapy in metastatic NSCLC and correlation with VEGF and Thrombospondin levels WCRJ 2017; 4 (2): e878.

● KDR gene as a Predictive Biomarker of Response to Regorafenib in Patients with Metastatic Colorectal Cancer (mCRC). Journal of Pharmacogenomics & Pharmacoproteomics. 2017;08(03).

● Prospective Analysis of Patients Treated with Chemotherapy in Metastatic Adenocarcinoma of Lung—Single Centre Experience. Journal of Cancer Therapy. 2017;08(09):838-844.

● Efficacy Study of Metronomic Chemotherapy in Metastatic Triple Negative Breast Cancer and Correlation with VEGF, TSP Levels. Advances in Breast Cancer Research. 2018;07(02):107-119.

● Prospective Analysis of Patients with Metastatic Breast Cancer receiving Eribulin Mesylate as Second or More Lines of Chemotherapy: An Indian Experience. Clin Med Insights Oncol. 2018 Jun 28;12:1179554918782475.

Awards & Accolades

● Dr. Srinivasa has served as a primary investigator and co-investigator for clinical trials conducted on various types of cancer, new chemotherapy drugs, and new immunotherapy drugs and has authored numerous publications in prestigious national and international peer-reviewed medical journals.

● He is the recipient of the 'President NBE Gold Medal' with certification by the National Board of Examination, New Delhi, for securing the highest marks in the medical oncology examination.

● Dr. Srinivasa firmly believes in the effectiveness of cancer awareness and is an active cancer awareness advocate.

Other Doctors